Jupiter Asset Management’s Syndax Pharmaceuticals SNDX Stock Holding History

Jupiter Asset Management’s Portfolio SNDX Stock Details SNDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.01M	Buy	+366,568	New	+$7.62M	0.04%	320

Other funds holding SNDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

VIG

Vienna Insurance Group Warsaw, Poland $381M AUM 105.39% 1-Year Est. Return

Jupiter Asset Management's SNDX Position: Q2 2026 in Review

Jupiter Asset Management opened a new position in Syndax Pharmaceuticals (SNDX) in Q2 2026: 366,568 shares worth $8.01M. The stake represents 0.04% of the portfolio and ranks #320 among its holdings.

72 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

Jupiter Asset Management held 366,568 shares of Syndax Pharmaceuticals worth $8.01M as of Q2 2026.
Syndax Pharmaceuticals was a new Jupiter Asset Management position in Q2 2026.
Syndax Pharmaceuticals made up 0.04% of Jupiter Asset Management's portfolio in Q2 2026, its #320 holding.
72 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on Jupiter Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.